In The News,

Prostate Cancer Prognostic Assay

Created a comprehensive payer launch engagement strategy for a prostate cancer prognostic assay, including timelines for engagement, strategic communication approaches, and a targeted group of payers known to be early adopters.

Interested in hearing more from us?

Receive customized email alerts from the ADVI team